keo ty le bong da hom nay Asia Group, LLC (“TAG”), a leading Washington-based strategic advisory firm supporting global businesses and investors across keo ty le bong da hom nay Indo-Pacific, is proud to announce its efforts as principal strategic and sales advisor to a groundbreaking collaboration and licensed production agreement between Arcturus Therapeutics Holdings Inc. (ARCT) and Vinbiocare Biotechnology JSC (a member of Vingroup JSC).
keo ty le bong da hom nay leading U.S-based cutting-edge vaccine and medicine development Arcturus has just announced that it will transfer its mRNA vaccine production technology to VinBioCare (a member of Vingroup).
Accordingly, keo ty le bong da hom nay potential single shot mRNA vaccine is undergoing phase 2 clinical trials in keo ty le bong da hom nay United States and Singapore, and promising clinical data demonstrates a favorable safety profile and both humoral and cellular immunogenicity against COVID-19. As part of this agreement, Arcturus will work with keo ty le bong da hom nay Government of Vietnam to develop a phase 3 trial to further demonstrate ARCT-021′s safety profile and efficacy for keo ty le bong da hom nay Vietnam market.
Behind this cutting-edge vaccine production technology transfer is keo ty le bong da hom nay Asia Group (“TAG”) – keo ty le bong da hom nay U.S-based premier strategic advisory firm. Specifically, TAG serves as keo ty le bong da hom nay key strategic and sales advisor to keo ty le bong da hom nay groundbreaking collaboration agreement to bring mRNA vaccine technology to Vietnam.
Mr. Nirav Patel, CEO and Co-Founder of TAG noted that: “TAG is excited to support our client’s strategic and commercial interests in one of keo ty le bong da hom nay most dynamic markets in keo ty le bong da hom nay world and in doing so providing keo ty le bong da hom nay people of Vietnam with cutting edge vaccines to address keo ty le bong da hom nay COVID-19 pandemic.”
Ms. Le Thi Thu Thuy, Vice Chairwoman of Vingroup said: “keo ty le bong da hom nay Asia Group team led by Nirav Patel has proven instrumental in supporting critical commercial investments of keo ty le bong da hom nay technology necessary to support keo ty le bong da hom nay people of Vietnam and enabling Vingroup and Arcturus’ strategic and commercial partnership. We look forward to continuing to work with keo ty le bong da hom nay TAG team as we look for new opportunities to expand our business.”
In addition to keo ty le bong da hom nay vaccine production technology transfer project, keo ty le bong da hom nay Asia Group is also known as keo ty le bong da hom nay leading strategic advisory firm that has connected many foreign businesses to invest in Vietnam or support Vietnamese businesses to find investment opportunities in keo ty le bong da hom nay global market.
Typically, keo ty le bong da hom nay Asia Group is a long-term strategic partner of An Phat Holdings – a pioneer corporation in Vietnam in keo ty le bong da hom nay production and research of environmentally friendly materials and products that meet international standards. Mr. Nirav Patel – CEO and Co-Founder of TAG is also a member of keo ty le bong da hom nay Board of Directors of An Phat Holdings.
For years, keo ty le bong da hom nay Asia Group and An Phat Holdings have collaborated on projects to develop and trade of green products. In which, An Phat Holdings is keo ty le bong da hom nay manufacturer of green products and materials while TAG is responsible for seeking potential partners, penetrating and expanding keo ty le bong da hom nay international market, especially keo ty le bong da hom nay US and North American countries.
An Phat Holdings has also actively supported keo ty le bong da hom nay Asia Group in successfully connecting this project.
